GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pideka Group Inc (OTCPK:CIMVF) » Definitions » Debt-to-Equity

Pideka Group (Pideka Group) Debt-to-Equity : 0.45 (As of Sep. 2021)


View and export this data going back to 2021. Start your Free Trial

What is Pideka Group Debt-to-Equity?

Pideka Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2021 was $1.67 Mil. Pideka Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2021 was $9.00 Mil. Pideka Group's Total Stockholders Equity for the quarter that ended in Sep. 2021 was $23.85 Mil. Pideka Group's debt to equity for the quarter that ended in Sep. 2021 was 0.45.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Pideka Group's Debt-to-Equity or its related term are showing as below:

CIMVF's Debt-to-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Pideka Group Debt-to-Equity Historical Data

The historical data trend for Pideka Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pideka Group Debt-to-Equity Chart

Pideka Group Annual Data
Trend
Debt-to-Equity

Pideka Group Quarterly Data
Mar20 Jun20 Sep20 Mar21 Jun21 Sep21
Debt-to-Equity Get a 7-Day Free Trial N/A N/A 1.20 0.42 0.45

Competitive Comparison of Pideka Group's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Pideka Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pideka Group's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pideka Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Pideka Group's Debt-to-Equity falls into.



Pideka Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Pideka Group's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Pideka Group's Debt to Equity Ratio for the quarter that ended in Sep. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pideka Group  (OTCPK:CIMVF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Pideka Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Pideka Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Pideka Group (Pideka Group) Business Description

Traded in Other Exchanges
N/A
Address
40 King Street West, 2100 Scotia Plaza, Toronto, ON, CAN, M5H 3C2
Pideka Group Inc is multi-national operator with a medical grade indoor cultivation facility and laboratory in Colombia which holds GMP-PHARMA and good agricultural and collection practice certifications, and a retail operation in California.